abstract OBJECTIVES: To describe the longitudinal relationship between height-for-age z score (HZ), growth velocity z score, energy intake, habitual physical activity (HPA), and sedentary time across Gross Motor Function Classification System (GMFCS) levels I to V in preschoolers with cerebral palsy (CP). were assessed 440 times between the age of 18 months and 5 years. Height/length ratio was measured or estimated via knee height. Population-based standards were used to calculate HZ and growth velocity z-score by age and sex categories. Feeding method (oral or tube) and gestational age at birth (GA) were collected from parents. Three-day ActiGraph and food diary data were used to measure HPA/sedentary time ratio and energy intake, respectively. Oropharyngeal dysphagia was rated with the Dysphagia Disorder Survey (part 2, Pediatric). Analysis was undertaken with mixed-effects regression models.
Growth is a fundamental marker of health and well-being in all children. 1 Children with cerebral palsy (CP), particularly those with moderate to severe functional limitations, grow differently from children with typical development. 2, 3 CP is defined as a group of permanent disorders of movement and posture attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain. 4 The etiology of poor growth in children with CP is hypothesized to include nutritional factors, physical factors, and factors related to the brain lesion itself. 5 Oropharyngeal dysphagia (OPD) is prevalent in up to 85% of children with CP across the spectrum of functional capacity. 6 Parent-reported difficulty with feeding and the resulting impact on dietary intake corresponds to decreased nutritional status as measured by height, weight, body fat stores, and muscle mass in children with moderate to severe CP, and the presence of a gastrostomy feeding tube has been associated with greater height and weight. 2, 7 Physical factors related to poor growth include the physical impairment and lower levels of physical activity observed in children with CP that result in decreased weight bearing and mechanical stress on bones, leading to decreased bone formation and bone growth in children with CP. 8, 9 Factors related to the brain lesion itself can affect growth directly, via negative neurotropic effects, or indirectly, via endocrine factors such as growth hormone deficiency. 10, 11 The prevalence of preterm birth and low birth weight (BW) is higher in children with CP, 12 and these factors are commonly associated with shorter stature in typically developing children. 13 To our knowledge the influence of preterm birth on growth in children with CP has not been elucidated. However, a recent study identified being small for gestational age as a significant predictor of short stature in children with CP aged 0 to 5 years born at ≥36 weeks' gestation. 14 Specific growth charts for children with CP have been developed to identify whether a child's pattern of growth is typical given his or her gross motor function. 2 These growth charts are descriptive, and although they do not necessarily depict desirable growth in this population, they may be used for early identification of nutritional or metabolic difficulties. 15 This article aims to investigate the longitudinal relationship between stature, growth velocity, energy intake, habitual physical activity (HPA), and sedentary time for each Gross Motor Function Classification System (GMFCS) level in children with CP aged 18 months to 5 years while controlling for OPD, gestational age at birth (GA), BW, and sex.
METHODS

Participants
Children with a diagnosis of CP born in Queensland between 2006 and 2009 were eligible to participate. Children entered the study from 18 months corrected age (CA), and measures were taken at either 18, 24, 30, or 36 months CA, then again at 36 or 48 months CA depending on the timing of their first assessment, and third at 60 months CA. Children entering the study aged >36 months did not have all 3 assessments. Some children were assessed on 4 occasions because of their participation in a separate substudy. 16 Children were recruited as part of the Queensland CP Child Study of Growth, Nutrition and Physical Activity (n = 182) 17 in conjunction with Queensland CP Child Study of Motor Function and Brain Development (n = 227). 18 Queensland-born children with a diagnosis of CP were eligible for inclusion. 4 Children with a progressive or neurodegenerative lesion were excluded from the study. 19 Written informed consent was obtained from the child's primary caretaker. 17, 18 
Growth Measures
Height or supine length was measured to the nearest completed millimeter on a portable stadiometer (Shorr Productions, Olney, MD). If direct measures of length or height were not available because of joint contractures, scoliosis, or involuntary movements making standing or lying straight difficult or impossible, height was estimated based on knee height and validated equations. 20 If estimated height was used for a child at 1 assessment, it was also used at all other available assessments to ensure consistency. Weight was measured to the nearest 100 g on chair scales (Seca, Hamburg, Germany). Two measures of height/ length ratio and weight were taken, and the average was used. Height z-scores (HZ) and weight z-scores were identified based on age-and sex-based norms from children with typical development. 21 To assess linear growth compared with expected age-and sex-specific growth over a defined time interval, growth velocity z-scores (GvZ) were calculated. If >2 measurement occasions were available for 1 child, growth velocity between each age gap was calculated if the interval was >0.8 years but <2.5 years. 22 The age used in the GvZ calculation was the midpoint age between the 2 assessments and will be referred to as age at GvZ calculation.
Risk Factors for Poor Growth
Children were classified on the GMFCS. 23 GA and BW were collected from parents during the initial physician interview. 17 Severity of OPD was determined from the Dysphagia Disorder Survey (DDS), Pediatric Part 2 raw score, a valid and reliable measure of dysphagia. 24 -26 It consists of a series of binary judgments of feeding competency on 8 ingestion functions for purée, chewable food, and fluids. Possible total scores range from 0 (no impairment) to 22 (profound impairment, including those fed exclusively via gastrostomy tube). 27 Feeding method (oral versus gastrostomy tube) was determined by parent report via questionnaire. Qualified dietitians, physiotherapists, and a pediatric speech pathologist assessed anthropometric measures, gross motor function, and mealtimes, respectively.
Modifi able Lifestyle Factors
Energy intake in megajoules was assessed with a validated weighed 3-day food and fluid diary. 16 Parents were supplied with food scales and a food diary with detailed instructions, and weighed food and fluid intake for 2 weekdays and a weekend day. 16 The food diaries were analyzed in FoodWorks 7 (Xyris Software, Brisbane, Australia). The 3-day average HPA (cpm) and sedentary time (percentage of the day) were measured on an ActiGraph activity monitor (model GT3M/GT3×; ActiGraph, Pensacola, FL), which has been validated in a young CP population. 28, 29 Parents were given an ActiGraph for their child to wear for 2 weekdays and a weekend day while they completed a wear time log. 8 
Analysis
Student's t tests and χ 2 tests were used to assess the association between clinical characteristics and study participation (more than once versus once only). Longitudinal analysis was undertaken via multilevel mixed-effects regression models, which account for repeat measurements within participants. 30 In all mixed-effects models a child's identification number was entered as a random effect. For the HZ analysis, the 5 GMFCS levels I to V were used. For the GvZ analysis 3 groupings (GMFCS I-II ambulatory, GMFCS III marginally ambulatory, and GMFCS IV-V nonambulatory) were used because of the small number of participants with >1 height measure point available in the GMFCS II and IV levels. Age-related changes were estimated, and variables significantly associated with the outcomes HZ and GvZ were identified. Variables investigated were sex, DDS score, gastrostomy tube feeding, BW, sedentary time, HPA, energy intake, and age terms (age at assessment, age at GvZ calculation, and GA). All continuous variables were centered at the lowest observed variable in the data set so as to not regress to, for example, a BW or GA of 0. Linear and quadratic age terms were used to investigate possible nonlinear relationships. When the models were built, first univariable analyses were conducted to identify variables significantly associated with the outcomes at the P < .25 level. Second, identified variables were entered into individual multivariable models that included GMFCS level as an explanatory variable. Third, all remaining variables significant at the P < .05 level after controlling for GMFCS level were included in a combined multivariable model. Variables were retained in the final model if they were statistically significant at P < .05 by the likelihood ratio test. Analyses were performed in Stata version 13.0 (Stata Corp, College Station, TX).
RESULTS
Participants
A total of 175 children participated in the CP child study, and in 147 (84%) of these GvZ could be calculated because they participated on >1 occasion. In total, 440 assessments were available for inclusion in the HZ analysis, and 241 pairs of growth measures were available for the GvZ analysis. Table 1 shows the number of children recruited at each age band and how many repeated measures were available. The distribution of GMFCS levels in the sample was representative of the Australian population of people with CP 12 but with a higher proportion of children classified as GMFCS I (47% vs 36%) and GMFCS III (16% vs 11%) and a lower proportion of children classified as GMFCS II (12% vs 25%). This difference could reflect the young age of the study population. 31 Participant characteristics by age group are displayed in Table 2 .
Stature
The associations between candidate variables and HZ are reported in Table 3 . Feeding method, GA, BW, DDS score, HPA, sedentary time, and energy intake were all identified as candidates for inclusion in a multivariable model including GMFCS level (P < .25). BW and GA both contributed significantly to the model at P < .05 when entered into a multivariate model that included GMFCS level, whereas HPA, sedentary time, DDS, feeding method, and energy intake did not and were excluded from additional testing. GA and BW were highly correlated (r 2 = 0.83, P < .001), and BW lost significance once GA was added to the combined model. GA had a quadratic effect. The final model for HZ includes interactions between GMFCS and age and GA.
The mixed-effects linear regression analysis of HZ ( Table 4 ; model A) showed that as a group, children with CP at 18 months of age had an HZ significantly below 0 (ie, their mean HZ score was significantly lower than what is expected in a typically developing population). HZ did not significantly change between 18 months and 5 years. When the sample was stratified by GMFCS ( Table 4 ; model B), HZ was not significantly different from 0 for GMFCS level I, but GMFCS levels II to V had an HZ significantly below that of GMFCS level I. In the final model the GA terms and the GMFCS by age at assessment term were introduced ( Table 4 ; model C). Preterm-born children in all GMFCS groups were significantly shorter than age-and sex-specific reference children with typical development. There is a significant, positive, curvilinear relationship between GA and HZ, so although HZ significantly increased for each week past 23 weeks a child was born, the increase diminished the closer to term a child was born ( Table 4 ; model C). The interaction of GMFCS and age at assessment showed that HZ significantly declined between the ages of 18 months and 5 years in GMFCS levels IV and V, whereas GMFCS level I showed a slight but significant improvement in HZ each year.
Growth Velocity
The association between candidate variables and GvZ are reported in Table 3 . The variables gastrostomy tube feeding, DDS score, sedentary time, and energy intake were identified for additional investigation in individual multivariable models (P < .25). None of the variables retained significance once GMFCS level was entered into the models. The mixedeffects analysis of GvZ ( Table 4 ; model D) showed that as a group, the GvZ of children with CP at the age of 18 months was not significantly below 0, and GvZ was stable between the ages of 18 months and 5 years. When GMFCS levels were added to the model ( Table 4 ; model E), the GvZ for children classified as GMFCS I to II was not significantly different from 0. The GvZ of GMFCS levels III and IV to V was significantly lower than that of GMFCS levels I to II ( Table 4 ; model E). There was no change in GvZ between the ages of 18 months and 5 years in any GMFCS level (Table 4 ; model E).
DISCUSSION
Children with CP who are able to ambulate independently (GMFCS I) did not differ from peers with typical development in terms of stature or growth velocity. This finding is in agreement with previous studies, but GMFCS levels I and II have not been explored separately. 2, 14 In this study, children who were able to ambulate independently with limitations (GMFCS II) were on average shorter than children in GMFCS level I but had a similar growth velocity. The stature of children who were marginally 4 by guest on October 31, 2017 http://pediatrics.aappublications.org/ Downloaded from ambulant (GMFCS III) or nonambulant (GMFCS IV-V) was significantly lower than children in GMFCS level I at the age of 18 months, and they grew more slowly than children in GMFCS level I. Slower growth will therefore cause a discrepancy in stature that will become even more apparent with age for children with moderate to severe gross motor limitations, in agreement with previous studies. 2, 3, 32 Prematurity was a significant predictor of short stature at 18 months for all children with CP regardless of GMFCS level but was not a significant predictor of growth velocity. The effect of GA on growth status in the study population remained constant between the ages of 18 months and 5 years, indicating that children born prematurely did not catch up to their peers born closer to term in this period. It is common clinical practice to use CA until the age of 2 years in children born prematurely (GA <37 weeks). This is done under the assumption that they will have caught up by then, but children born very prematurely may never catch up or may do so at a much later age. 33, 34 Feeding method or feeding difficulties as measured by OPD severity did not significantly predict stature or growth velocity. This finding is contrary to previous studies, but wider age ranges may have influenced results, because time since tube insertion and duration of feeding difficulties may have an influence on growth. 2, 7 Contrary to the findings reported in this article, a recent longitudinal study of children with CP aged 0 to 5 years born at ≥36 weeks' GA did not identify slower growth in the GMFCS III to V group. 14 This study did identify a significantly lower HZ in children classified as GMFCS III to V versus GMFCS I to II, but this difference lost significance once children with feeding difficulties were excluded from the sample. This result is in contrast to our findings, where feeding difficulties as measured by severity of OPD were not a significant predictor of HZ. The smaller sample size, reliance on height data collected via public health center records, and use of parentreported feeding difficulties may explain the discrepancies between the findings of that study and the findings presented in this article. 14 Using growth velocity compared with a static measure of stature allows better understanding of the factors operative during the growth interval. 35 The identification of a growth velocity slower than that observed in children with typical development may imply growth failure and be of more clinical value than height per se. The use of growth velocity should therefore be more accurate than stature when investigating factors contributing to slower growth in the CP population. 35 Energy intake did not show a significant relationship to stature and growth velocity in our population. Linear growth has previously been found to slow down with age in children with CP independent of nutritional status, 32 and attempts to improve growth through gastrostomy feeding have also been shown to improve weight z score but not height z score. 36 Lower levels of physical activity and lack of weight bearing have been suggested as contributing factors to poor growth. 5, 10 As in other studies of the CP population, children with milder motor disability were found to grow faster than those with moderate to severe motor disability. 2, 3, 32 A stepwise increase in sedentary time with decreasing gross motor function has been reported previously. 8 Although there was some evidence of possible relationships 5 ( Table 3) , these correlations between growth and measures of HPA and sedentary behavior are largely explained by the level of gross motor capacity. The differentiation of ambulant versus marginally ambulant and nonambulant may be sufficient for explaining the effect of HPA and sedentary behavior on growth. Validation and use of more sophisticated features of the ActiGraph such as an inclinometer to assess standing and sitting time could provide an even more detailed description of a child's daily activity level and therefore reveal relationships to growth. For example, length of time in a standing frame for children with severe motor disabilities could have an impact on their growth. 37 The strengths of the current study include longitudinal prospective data collection of a representative population cohort of children with CP, all measured by trained study staff. Measures of HPA, sedentary time, energy intake, and OPD validated specifically for the young CP population were used. 16, 25, 28, 29 A limitation of the study was missing data for physical activity, caused by the difficulty of collecting these data for some families. Because the sample sizes were fixed, post hoc power calculations were performed in PS Power and Sample Size Program (Version 3), with simplified assumptions and linear regression equations. 38 In the sample size of 94 children with activity data, the post hoc analysis shows that it would be possible to detect an increase in HZ of ≥0.08 for each 100-cpm increase in HPA with 80% power and 5% significance, which was of small magnitude, and it was therefore of low probability that a clinically significant relationship would go undetected.
CONCLUSIONS
When the growth of young children with CP is assessed in a clinical setting, both gross motor capacity and GA should be taken into consideration. Although children classified as GMFCS I to II appear to be growing at a rate similar to their peers with typical development, children classified as GMFCS III to V grow more slowly. These children also spend more time sedentary and have lower levels of HPA than peers classified as GMFCS I to II and those who are typically developing. More research into the causes and consequences of slower growth, novel interventions aimed at decreasing sedentary time and increasing HPA in GMFCS levels III to V, and their effect on growth and other health outcomes is warranted.
